Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 1Phase 1/2 1

Status

Recruiting 5Not yet recruiting 1Available 1Active not recruiting 1

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Other solid neoplasm 5

Conditions

Breast Neoplasms 1789Neoplasms 1516Carcinoma, Non-Small-Cell Lung 1053Prostatic Neoplasms 965Colorectal Neoplasms 889Lung Neoplasms 809Pancreatic Neoplasms 583Carcinoma, Hepatocellular 543Leukemia, Myeloid, Acute 540Stomach Neoplasms 523Ovarian Neoplasms 513Neoplasm Metastasis 492Multiple Myeloma 491Recurrence 417Melanoma 390Squamous Cell Carcinoma of Head and Neck 374Uterine Cervical Neoplasms 366Brain Neoplasms 364Head and Neck Neoplasms 355Esophageal Neoplasms 320Precursor Cell Lymphoblastic Leukemia-Lymphoma 313Endometrial Neoplasms 311Lymphoma 309Triple Negative Breast Neoplasms 301Glioblastoma 298Rectal Neoplasms 284Urinary Bladder Neoplasms 268Sarcoma 266Hematologic Neoplasms 266Colonic Neoplasms 257

Interventions

Paclitaxel 2Pemetrexed 1Oxaliplatin 1Etoposide 1Drug Therapy 1Docetaxel 1Cisplatin 1Carboplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Advanced Solid Tumor Cancer × Clear all
NCT07455734 2026-05-14

Early-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors

BioNTech SE

Phase 1/2 Recruiting
533 enrolled
Other solid neoplasm

Advanced Solid Tumor Cancer

NCT07477743 2026-03-17

A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combinations in Advanced Solid Tumors

HC Biopharma Inc.

Phase 1 Recruiting
331 enrolled
Other solid neoplasm

Advanced Solid Tumor Cancer

NCT07387081 2026-02-04

Phase II Study of LM-24C5

LaNova Medicines Limited

Phase 2 Recruiting
130 enrolled
Other solid neoplasm

Advanced Solid Tumor Cancer

NCT07381829 2026-02-02

A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combined With Chemotherapy in Lung Cancer

HC Biopharma Inc.

Phase 1 Recruiting
328 enrolled
Other solid neoplasm

Advanced Solid Tumor Cancer

NCT07139067 2025-08-24

YK1101

Peking University

Phase 1 Recruiting
10 enrolled
Other solid neoplasm

Advanced Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡